Shandong Huizhi Pharmaceutical Technology

Shandong Huizhi Pharmaceutical Technology is a comprehensive pharmaceutical R&D and technical service provider headquartered in Jinan, China. The company offers a wide range of services including drug discovery, process chemistry, formulation development, and clinical research, operating as both a Contract Research Organization (CRO) and a Contract Development and Manufacturing Organization (CDMO). Huizhi Pharmaceutical is particularly recognized for its expertise in the consistency evaluation of generic drugs and the development of complex small molecule therapeutics. By integrating research, development, and production, the company supports pharmaceutical clients in accelerating the path from laboratory to market across various therapeutic categories. Their technical capabilities span multiple areas such as oncology, cardiovascular health, and anti-infectives, serving both domestic and international pharmaceutical clients. The company operates state-of-the-art R&D facilities and a GMP-compliant manufacturing base to ensure high-quality standards for APIs and intermediates.